Your browser doesn't support javascript.
loading
Liver Transplantation for Nonresectable Colorectal Liver Metastases (CRLM).
Malik, Abdullah K; Mahendran, Balaji; Lochan, Rajiv; White, Steven A.
Afiliação
  • Malik AK; Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Mahendran B; NIHR Blood and Transplant Research Unit, Newcastle University, Newcastle Upon Tyne, UK.
  • Lochan R; Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • White SA; NIHR Blood and Transplant Research Unit, Newcastle University, Newcastle Upon Tyne, UK.
Indian J Surg Oncol ; 15(Suppl 2): 255-260, 2024 May.
Article em En | MEDLINE | ID: mdl-38818008
ABSTRACT
Transplantation represents the most radical locoregional therapy through removal of the liver, associated vasculature and locoregional lymph nodes, and replacing it with an allograft. Recent evidence has demonstrated that transplantation for unresectable CRLM is feasible with acceptable post-transplant outcomes in a highly selected cohort of patients. Controversy exists regarding whether transplantation is an appropriate treatment for such patients, due to concerns regarding disease recurrence in the transplanted graft in an immunosuppressed recipient along with utilising a donor liver which are in short supply. Expanding the indications for liver transplantation may also limit access for other patients with end-stage liver disease having ethical implications due to the effect of increasing the waiting list. In this review, we summarise the current evidence for liver transplantation in patients with nonresectable CRLM and highlight unresolved controversies and future directions for this type of treatment.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article